Literature DB >> 19780197

Interaction of NG2(+) glial progenitors and microglia/macrophages from the injured spinal cord.

Junfang Wu1, Soonmoon Yoo, Donna Wilcock, Judith M Lytle, Philberta Y Leung, Carol A Colton, Jean R Wrathall.   

Abstract

Spinal cord contusion produces a central lesion surrounded by a peripheral rim of residual white matter. Despite stimulation of NG2(+) progenitor cell proliferation, the lesion remains devoid of normal glia chronically after spinal cord injury (SCI). To investigate potential cell-cell interactions of the predominant cells in the lesion at 3 days after injury, we used magnetic activated cell sorting to purify NG2(+) progenitors and OX42(+) microglia/macrophages from contused rat spinal cord. Purified NG2(+) cells from the injured cord grew into spherical masses when cultured in defined medium with FGF2 plus GGF2. The purified OX42(+) cells did not form spheroids and significantly reduced sphere growth by NG2(+) cells in co-cultures. Conditioned medium from these OX42(+) cells, unlike that from normal peritoneal macrophages or astrocytes also inhibited growth of NG2(+) cells, suggesting inhibition by secreted factors. Expression analysis of freshly purified OX42(+) cells for a panel of six genes for secreted factors showed expression of several that could contribute to inhibition of NG2(+) cells. Further, the pattern of expression of four of these, TNFalpha, TSP1, TIMP1, MMP9, in sequential coronal tissue segments from a 2 cm length of cord centered on the injury epicenter correlated with the expression of Iba1, a marker gene for OX42(+) cells, strongly suggesting a potential regional influence by activated microglia/macrophages on NG2(+) cells in vivo after SCI. Thus, the nonreplacement of lost glial cells in the central lesion zone may involve, at least in part, inhibitory factors produced by microglia/macrophages that are concentrated within the lesion. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19780197      PMCID: PMC2807472          DOI: 10.1002/glia.20932

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  44 in total

1.  Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion.

Authors:  S D Grossman; L J Rosenberg; J R Wrathall
Journal:  Exp Neurol       Date:  2001-04       Impact factor: 5.330

2.  FGF-2 is sufficient to isolate progenitors found in the adult mammalian spinal cord.

Authors:  L S Shihabuddin; J Ray; F H Gage
Journal:  Exp Neurol       Date:  1997-12       Impact factor: 5.330

3.  Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies.

Authors:  Xiaoqing Yuan; Ramesh Chittajallu; Shibeshih Belachew; Stacie Anderson; Chris J McBain; Vittorio Gallo
Journal:  J Neurosci Res       Date:  2002-11-15       Impact factor: 4.164

4.  Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells.

Authors:  Qilin Cao; Xiao-Ming Xu; William H Devries; Gaby U Enzmann; Peipei Ping; Pantelis Tsoulfas; Patrick M Wood; Mary Bartlett Bunge; Scott R Whittemore
Journal:  J Neurosci       Date:  2005-07-27       Impact factor: 6.167

5.  Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury.

Authors:  P Ye; A J D'Ercole
Journal:  Endocrinology       Date:  1999-07       Impact factor: 4.736

6.  Endogenous repair after spinal cord contusion injuries in the rat.

Authors:  M S Beattie; J C Bresnahan; J Komon; C A Tovar; M Van Meter; D K Anderson; A I Faden; C Y Hsu; L J Noble; S Salzman; W Young
Journal:  Exp Neurol       Date:  1997-12       Impact factor: 5.330

7.  Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix.

Authors:  J H Uhm; N P Dooley; L Y Oh; V W Yong
Journal:  Glia       Date:  1998-01       Impact factor: 7.452

8.  Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan.

Authors:  Peter H Larsen; Jennifer E Wells; William B Stallcup; Ghislain Opdenakker; V Wee Yong
Journal:  J Neurosci       Date:  2003-12-03       Impact factor: 6.167

9.  NF-kappaB prevents TNF-alpha-induced apoptosis in an oligodendrocyte cell line.

Authors:  Makoto Hamanoue; Akira Yoshioka; Toya Ohashi; Yoshikatsu Eto; Ken Takamatsu
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

10.  PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination.

Authors:  Emma E Frost; Joseph A Nielsen; Tuan Q Le; Regina C Armstrong
Journal:  J Neurobiol       Date:  2003-02-15
View more
  23 in total

1.  Deletion of the Fractalkine Receptor, CX3CR1, Improves Endogenous Repair, Axon Sprouting, and Synaptogenesis after Spinal Cord Injury in Mice.

Authors:  Camila M Freria; Jodie C E Hall; Ping Wei; Zhen Guan; Dana M McTigue; Phillip G Popovich
Journal:  J Neurosci       Date:  2017-03-06       Impact factor: 6.167

2.  Inhibition of NOX2 signaling limits pain-related behavior and improves motor function in male mice after spinal cord injury: Participation of IL-10/miR-155 pathways.

Authors:  Boris Sabirzhanov; Yun Li; Marino Coll-Miro; Jessica J Matyas; Junyun He; Alok Kumar; Nicole Ward; Jingwen Yu; Alan I Faden; Junfang Wu
Journal:  Brain Behav Immun       Date:  2019-02-23       Impact factor: 7.217

3.  Microglial inhibitory factor (MIF/TKP) mitigates secondary damage following spinal cord injury.

Authors:  Jaime Emmetsberger; Stella E Tsirka
Journal:  Neurobiol Dis       Date:  2012-05-14       Impact factor: 5.996

Review 4.  Oligodendrocyte fate after spinal cord injury.

Authors:  Akshata Almad; F Rezan Sahinkaya; Dana M McTigue
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 5.  Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?

Authors:  Nicole Pukos; Matthew T Goodus; Fatma R Sahinkaya; Dana M McTigue
Journal:  Glia       Date:  2019-08-24       Impact factor: 7.452

Review 6.  The Biology of Regeneration Failure and Success After Spinal Cord Injury.

Authors:  Amanda Phuong Tran; Philippa Mary Warren; Jerry Silver
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 7.  Role of microglia in neurotrauma.

Authors:  David J Loane; Kimberly R Byrnes
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

8.  Intraspinal Delivery of Polyethylene Glycol-coated Gold Nanoparticles Promotes Functional Recovery After Spinal Cord Injury.

Authors:  Florentia Papastefanaki; Igor Jakovcevski; Nafsika Poulia; Nevena Djogo; Florian Schulz; Tamara Martinovic; Darko Ciric; Gabrielle Loers; Tobias Vossmeyer; Horst Weller; Melitta Schachner; Rebecca Matsas
Journal:  Mol Ther       Date:  2015-03-25       Impact factor: 11.454

9.  Delayed cell cycle pathway modulation facilitates recovery after spinal cord injury.

Authors:  Junfang Wu; Bogdan A Stoica; Michael Dinizo; Ahdeah Pajoohesh-Ganji; Chunshu Piao; Alan I Faden
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

10.  Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders.

Authors:  R Lee Mosley; Howard E Gendelman
Journal:  Exp Neurol       Date:  2010-01-04       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.